Targeted Therapy Plus Chemotherapy May Pack 1-2 Punch Against Me...

Courtesy ScienceDaily  Fri, 05/16/2008 - 09:15

By targeting and disabling a protein frequently found in melanoma tumors, doctors may be able to make the cancer more vulnerable to chemotherapy, according to a new study.

Although this study was done in laboratory rats, a clinical trial applying the same concept to humans has already begun at four comprehensive cancer centers nationwide.

Tags:

 

Related news items

Clinical Trial Shows Reduction In Mortality For Children With Se...
Introducing an increased intensity of chemotherapy in children with severe Langerhans cell histiocytosis can reduce the mortality rate for this...

Counting Tumor Cells In Blood Predicts Treatment Benefit In Pros...
Counting the number of tumor cells circulating in the bloodstream of patients with castration-resistant prostate cancer can accurately predict how...

First Gene Therapy For Heart Failure Offered In Clinical Trials
Could injecting a gene into a patient with severe heart failure reverse their disabling and life-threatening condition? Physician-scientists are...

Are HIV Prevention Gels Safe For Pregnant Women, Their Babies?
Clinical trials hoping to identify a vaginal microbicide that is safe and effective against HIV have all but skirted questions befitting evaluation...

Blood Substitute's Effectiveness And Safety Addressed In Large C...
A blood substitute's effectiveness and safety was addressed in a large Phase III clinical trial by academic and industry researchers.


 

Post new comment

The content of this field is kept private and will not be shown publicly.
science-nature.marc8.com